Trial NCT02737072

View at ClinicalTrials.gov 
Org. Study IDs: 16387
Secondary IDs: I2V-MC-CXAD

Last trial update was posted on 2019-08-12

MeSH Interventions

Durvalumab

MeSH Conditions

Neoplasms

Other Conditions

Solid Tumor

Stopping Reasons

N/A

Limitations And Caveats

The study was terminated after the Phase 1a part was complete.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID